Most Crowded Stocks

Shares held by high-turnover 13F filers and by advisers to private funds, as a share of shares outstanding

Quarter:

Top 100 of 2,960 ranked listings

#	Stock	Crowding	Percentile	Crowded holders	Private funds	Institutional	13F filers
1	VRM Vroom, Inc.	86.7%	100th	9	86.7%	93.5%	36
2	DSGR Distribution Solutions Group, Inc.	85.0%	100th	41	84.3%	92.6%	114
3	CTOS Custom Truck One Source, Inc.	82.2%	100th	76	81.7%	97.8%	186
4	INM InMed Pharmaceuticals Inc.	80.5%	100th	14	77.0%	81.4%	20
5	SABS SAB Biotherapeutics, Inc.	73.0%	100th	36	71.2%	89.5%	87
6	BALY Bally's Corp	72.7%	100th	17	72.6%	77.7%	64
7	ACTG Acacia Research Corp	72.4%	100th	42	71.8%	89.1%	122
8	EVMN Evommune, Inc.	68.9%	100th	51	67.4%	96.0%	105
9	YCY AA Mission Acquisition Corp. II	68.5%	100th	27	57.0%	91.2%	39
10	SGP SpyGlass Pharma, Inc.	67.7%	100th	14	67.7%	78.1%	52
11	KLRS Kalaris Therapeutics, Inc.	67.6%	100th	24	67.3%	75.8%	56
12	BNTC Benitec Biopharma Inc.	67.4%	100th	36	67.3%	96.5%	86
13	AIV Apartment Investment & Management Co	67.3%	100th	71	65.1%	83.9%	155
14	PEPG PepGen Inc.	66.9%	100th	39	66.1%	75.3%	71
15	ADGM Adagio Medical Holdings, Inc.	66.4%	100th	14	63.1%	67.9%	24
16	FEMY Femasys Inc	64.2%	99th	4	0.590%	68.6%	18
17	HHH Howard Hughes Holdings Inc.	63.5%	99th	95	62.0%	90.8%	305
18	SWIM Latham Group, Inc.	63.5%	99th	54	58.4%	92.8%	134
19	CLYM Climb Bio, Inc.	63.4%	99th	51	61.8%	98.4%	108
20	AIB AIB Data Centers Inc.	62.9%	99th	23	58.5%	73.4%	36
21	OFIX Orthofix Medical Inc.	62.8%	99th	56	62.6%	94.7%	143
22	LRMR Larimar Therapeutics, Inc.	62.7%	99th	78	61.9%	91.9%	163
23	LAB Standard Biotools Inc.	61.2%	99th	66	59.4%	75.9%	143
24	ZYME Zymeworks Inc.	61.0%	99th	71	57.9%	93.6%	202
25	CURV Torrid Holdings Inc.	60.8%	99th	27	60.0%	90.5%	89
26	TACO Berto Acquisition Corp.	60.7%	99th	46	54.6%	75.1%	63
27	SEG Seaport Entertainment Group Inc.	60.4%	99th	34	60.3%	86.9%	116
28	TBPH Theravance Biopharma, Inc.	60.3%	99th	67	57.0%	93.3%	180
29	BEEP Mobile Infrastructure Corp	60.2%	99th	19	60.0%	63.9%	57
30	STRO Sutro Biopharma, Inc.	60.2%	99th	44	59.4%	99.5%	100
31	GRNT Granite Ridge Resources, Inc.	59.8%	99th	74	59.2%	84.3%	171
32	KOD Kodiak Sciences Inc.	59.6%	99th	78	59.0%	96.6%	200
33	ESTA Establishment Labs Holdings Inc.	58.6%	99th	86	53.7%	95.4%	196
34	GENB Generate Biomedicines, Inc.	58.4%	99th	29	58.4%	78.0%	86
35	DMII Drugs Made In America Acquisition II Corp.	58.3%	99th	50	46.5%	71.4%	70
36	RLMD Relmada Therapeutics, Inc.	58.1%	99th	57	56.1%	95.6%	126
37	ANRO Alto Neuroscience, Inc.	57.9%	99th	47	57.7%	84.0%	114
38	KRSA Korsana Biosciences, Inc.	57.4%	99th	9	56.8%	74.8%	20
39	ELME Elme Communities	57.1%	99th	67	43.4%	74.6%	159
40	TIC TIC Solutions, Inc.	57.1%	99th	76	52.3%	84.6%	213
41	AVBP ArriVent BioPharma, Inc.	56.9%	99th	65	54.2%	99.0%	157
42	ATEX Anterix Inc.	56.6%	99th	73	55.4%	98.0%	171
43	FGII FG Imperii Acquisition Corp.	56.5%	99th	32	55.7%	66.2%	43
44	SPRY ARS Pharmaceuticals, Inc.	56.3%	99th	81	55.3%	91.2%	208
45	AKA A.K.A. Brands Holding Corp.	56.3%	99th	8	56.3%	56.4%	21
46	PHAT Phathom Pharmaceuticals, Inc.	56.3%	98th	63	55.3%	90.4%	161
47	LONA LeonaBio, Inc.	56.1%	98th	20	55.9%	77.4%	44
48	IPSC Century Therapeutics, Inc.	55.5%	98th	44	55.4%	87.6%	100
49	IKT Inhibikase Therapeutics, Inc.	55.4%	98th	44	47.1%	89.3%	105
50	IBIO iBio, Inc.	55.2%	98th	28	53.2%	69.9%	55
51	XTNT Xtant Medical Holdings, Inc.	54.2%	98th	11	54.1%	57.2%	32
52	ATII Archimedes Tech SPAC Partners II Co.	54.0%	98th	37	41.4%	59.5%	51
53	INAC Indigo Acquisition Corp.	53.4%	98th	28	48.7%	68.1%	41
54	IRHO Iron Horse Acquisition II Corp.	53.4%	98th	38	44.7%	66.7%	55
55	AGL agilon health, inc.	52.8%	98th	84	48.1%	97.0%	179
56	AURA Aura Biosciences, Inc.	52.8%	98th	63	52.4%	92.3%	146
57	SNDA Sonida Senior Living, Inc.	52.7%	98th	78	52.4%	78.8%	229
58	CVEO Civeo Corp	52.5%	98th	36	49.9%	85.1%	95
59	PRLD Prelude Therapeutics Inc	52.5%	98th	38	48.2%	62.3%	75
60	ANTX AN2 Therapeutics, Inc.	52.4%	98th	30	49.6%	68.3%	66
61	JANX Janux Therapeutics, Inc.	52.4%	98th	85	41.6%	99.7%	197
62	LOCO El Pollo Loco Holdings, Inc.	52.4%	98th	64	49.6%	93.3%	151
63	ACI Albertsons Companies, Inc.	51.9%	98th	140	51.0%	93.5%	448
64	LOVE Lovesac Co	51.8%	98th	45	47.2%	96.6%	120
65	PED Pedevco Corp	51.7%	98th	5	51.7%	56.1%	30
66	ACAD Acadia Pharmaceuticals Inc	51.7%	98th	108	50.1%	98.5%	354
67	RNA Atrium Therapeutics, Inc.	51.6%	98th	62	49.0%	83.8%	154
68	NKTX Nkarta, Inc.	51.6%	98th	56	47.2%	82.9%	135
69	PALI Palisade Bio, Inc.	51.5%	98th	56	43.4%	99.9%	124
70	OKUR OnKure Therapeutics, Inc.	51.3%	98th	32	45.7%	86.3%	75
71	AOUT American Outdoor Brands, Inc.	51.3%	98th	35	48.7%	69.0%	98
72	PAAC Proem Acquisition Corp. I	51.2%	98th	26	48.6%	57.7%	32
73	IMDX Insight Molecular Diagnostics Inc.	51.2%	98th	16	50.0%	57.2%	40
74	JHG Janus Henderson Group Ltd.	51.1%	98th	132	48.0%	90.1%	422
75	IRD Opus Genetics, Inc.	50.9%	98th	45	50.0%	70.7%	103
76	NCMI National CineMedia, Inc.	50.8%	97th	39	50.7%	89.4%	108
77	KPTI Karyopharm Therapeutics Inc.	50.8%	97th	43	47.5%	93.4%	96
78	ERAS Erasca, Inc.	50.5%	97th	103	48.6%	90.2%	256
79	WW Ww International, Inc.	50.3%	97th	27	35.1%	77.9%	78
80	ALXO Alx Oncology Holdings Inc	50.1%	97th	36	49.9%	78.2%	93
81	PVLA Palvella Therapeutics, Inc.	50.0%	97th	71	49.1%	98.2%	196
82	ZURA Zura Bio Ltd	49.9%	97th	41	49.6%	76.8%	95
83	BBOT BridgeBio Oncology Therapeutics, Inc.	49.7%	97th	30	49.4%	73.8%	65
84	AVLN Avalyn Pharma Inc.	49.6%	97th	45	48.4%	100.0%	93
85	RLYB Rallybio Corp	49.5%	97th	18	47.5%	76.7%	37
86	EMPD Empery Digital Inc.	49.5%	97th	21	37.7%	60.9%	37
87	AIOT Powerfleet, Inc.	49.4%	97th	73	47.4%	85.8%	181
88	SPRB Spruce Biosciences, Inc.	49.4%	97th	26	40.3%	72.9%	64
89	ORIQ Origin Investment Corp I	49.2%	97th	18	46.3%	78.8%	29
90	ACRS Aclaris Therapeutics, Inc.	49.2%	97th	63	48.1%	85.3%	148
91	RCKT Rocket Pharmaceuticals, Inc.	49.1%	97th	75	43.8%	91.3%	180
92	JYNT JOINT Corp	48.9%	97th	37	45.4%	67.9%	84
93	MLAB Mesa Laboratories Inc /Co/	48.9%	97th	62	45.0%	91.1%	159
94	WVE Wave Life Sciences, Inc.	48.7%	97th	94	46.4%	94.9%	239
95	OLN OLIN Corp	48.5%	97th	122	47.5%	99.8%	414
96	JATT JATT II Acquisition Corp.	48.3%	97th	18	48.3%	67.8%	25
97	STRT Strattec Security Corp	48.2%	97th	39	47.3%	88.0%	121
98	LAFA LaFayette Acquisition Corp.	48.1%	97th	29	46.3%	66.6%	44
99	QRED QuasarEdge Acquisition Corp	48.0%	97th	20	40.1%	60.7%	29
100	WHWK Whitehawk Therapeutics, Inc.	47.9%	97th	33	47.7%	87.4%	77

How crowding is measured

Each closed quarter, every 13F filer's common-share book is folded into per-listing totals. A filer counts toward crowding when its measured turnover is high (the smaller of its buys and sells over the last four quarters is 100% or more of its average book) or when it advises private funds on Form ADV. Crowding divides those filers' shares by the company's newest cover-page shares outstanding dated by the quarter end; companies with more than one class of common stock, or whose count is in ordinary shares, are left out because their count is a different unit from one listing's shares.